These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 32668503

  • 21. Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactions.
    Hu H, Fu Y, Li M, Xia H, Liu Y, Sun X, Hu Y, Song F, Cheng X, Li P, Wu Y.
    Int Immunopharmacol; 2020 Sep; 86():106725. PubMed ID: 32679538
    [Abstract] [Full Text] [Related]

  • 22. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.
    Chattopadhyay R, Raghavan S, Rao GN.
    Redox Biol; 2017 Aug; 12():438-455. PubMed ID: 28319894
    [Abstract] [Full Text] [Related]

  • 23. RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages.
    Zhang HW, Wang Q, Mei HX, Zheng SX, Ali AM, Wu QX, Ye Y, Xu HR, Xiang SY, Jin SW.
    Int Immunopharmacol; 2019 Nov; 76():105877. PubMed ID: 31522017
    [Abstract] [Full Text] [Related]

  • 24. Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response.
    Chen F, Fan XH, Wu YP, Zhu JL, Wang F, Bo LL, Li JB, Bao R, Deng XM.
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):457-64. PubMed ID: 24072678
    [Abstract] [Full Text] [Related]

  • 25. Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-κB and MAPK pathways and activating the Nrf2 pathway in mice.
    Li J, Deng X, Bai T, Wang S, Jiang Q, Xu K.
    Int Immunopharmacol; 2020 Nov; 88():106961. PubMed ID: 33182038
    [Abstract] [Full Text] [Related]

  • 26. Resolvin D1 attenuates ventilator-induced lung injury by reducing HMGB1 release in a HO-1-dependent pathway.
    Sun Z, Wang F, Yang Y, Wang J, Sun S, Xia H, Yao S.
    Int Immunopharmacol; 2019 Oct; 75():105825. PubMed ID: 31437789
    [Abstract] [Full Text] [Related]

  • 27. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Hiram R, Xiong F, Naud P, Xiao J, Sirois M, Tanguay JF, Tardif JC, Nattel S.
    Cardiovasc Res; 2021 Jun 16; 117(7):1776-1789. PubMed ID: 32866246
    [Abstract] [Full Text] [Related]

  • 28. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.
    Halade GV, Kain V, Serhan CN.
    FASEB J; 2018 Jul 16; 32(7):3717-3729. PubMed ID: 29455574
    [Abstract] [Full Text] [Related]

  • 29. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
    Tang H, Liu Y, Yan C, Petasis NA, Serhan CN, Gao H.
    J Immunol; 2014 Oct 01; 193(7):3769-78. PubMed ID: 25172497
    [Abstract] [Full Text] [Related]

  • 30. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells.
    Zhang X, Wang T, Gui P, Yao C, Sun W, Wang L, Wang H, Xie W, Yao S, Lin Y, Wu Q.
    Oxid Med Cell Longev; 2013 Oct 01; 2013():185715. PubMed ID: 24381712
    [Abstract] [Full Text] [Related]

  • 31. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
    Luo B, Han F, Xu K, Wang J, Liu Z, Shen Z, Li J, Liu Y, Jiang M, Zhang ZY, Zhang Z.
    J Neurosci; 2016 Sep 14; 36(37):9590-603. PubMed ID: 27629711
    [Abstract] [Full Text] [Related]

  • 32. Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice.
    Hardesty JE, Warner JB, Song YL, Rouchka EC, McClain CJ, Warner DR, Kirpich IA.
    FASEB J; 2023 Jan 14; 37(1):e22705. PubMed ID: 36520060
    [Abstract] [Full Text] [Related]

  • 33. Interleukin-5 deletion promotes sepsis-induced M1 macrophage differentiation, deteriorates cardiac dysfunction, and exacerbates cardiac injury via the NF-κB p65 pathway in mice.
    Liang W, Li J, Bai C, Chen Y, Li Y, Huang G, Wang X.
    Biofactors; 2020 Nov 14; 46(6):1006-1017. PubMed ID: 33043521
    [Abstract] [Full Text] [Related]

  • 34. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.
    Hsiao HM, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, Olsen KC, Pollock SJ, Serhan CN, Phipps RP, Sime PJ.
    PLoS One; 2013 Nov 14; 8(3):e58258. PubMed ID: 23484005
    [Abstract] [Full Text] [Related]

  • 35. Gracillin inhibits apoptosis and inflammation induced by lipopolysaccharide (LPS) to alleviate cardiac injury in mice via improving miR-29a.
    Song YX, Ou YM, Zhou JY.
    Biochem Biophys Res Commun; 2020 Mar 12; 523(3):580-587. PubMed ID: 31941605
    [Abstract] [Full Text] [Related]

  • 36. Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression.
    Lee HN, Kundu JK, Cha YN, Surh YJ.
    J Cell Sci; 2013 Sep 01; 126(Pt 17):4037-47. PubMed ID: 23788426
    [Abstract] [Full Text] [Related]

  • 37. The anti-inflammatory and pro-resolution effects of aspirin-triggered RvD1 (AT-RvD1) on peripheral blood mononuclear cells from patients with severe asthma.
    Zambalde ÉP, Teixeira MM, Favarin DC, de Oliveira JR, Magalhães ML, Cunha MM, Silva WC, Okuma CH, Rodrigues V, Levy BD, Rogerio AP.
    Int Immunopharmacol; 2016 Jun 01; 35():142-148. PubMed ID: 27044027
    [Abstract] [Full Text] [Related]

  • 38. The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury.
    Zhang J, Wang M, Ye J, Liu J, Xu Y, Wang Z, Ye D, Zhao M, Wan J.
    Front Pharmacol; 2020 Jun 01; 11():203. PubMed ID: 32256344
    [Abstract] [Full Text] [Related]

  • 39. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M, Su G, Salmon MD, Lu G, Cullen JM, Fashandi AZ, Hawkins RB, Montgomery W, Meher AK, Conte MS, Sharma AK, Ailawadi G, Upchurch GR.
    J Vasc Surg; 2018 Dec 01; 68(6S):93S-103S. PubMed ID: 30470363
    [Abstract] [Full Text] [Related]

  • 40. Xuebijing Injection () and Resolvin D1 Synergize Regulate Leukocyte Adhesion and Improve Survival Rate in Mice with Sepsis-Induced Lung Injury.
    Zhang SK, Zhuo YZ, Li CX, Yang L, Gao HW, Wang XM.
    Chin J Integr Med; 2018 Apr 01; 24(4):272-277. PubMed ID: 28497397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.